17
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Myoglobin kinetics in patients suffering from acute myocardial infarction in its early phase —as studied by the single injection method

&
Pages 79-85 | Received 08 Apr 1980, Accepted 25 Jun 1980, Published online: 08 Jul 2009
 

Abstract

The turnover of myoglobin has been examined with the single injection technique in eight patients suffering from acute myocardial infarction during its early phase. All patients had elevated serum levels of myoglobin and creatine kinase-MB. The serum disappearance curve of [125I]myoglobin could be fitted adequately by a two-compartment model. The kinetic parameters did not differ from those estimated for six healthy old volunteers, previously studied with the same technique. The average elimination rate constant was 0.80 ± 0.37 h−1 and the average turnover time was 5.5 ± 3.2 h (SD). The values are in good agreement with corresponding estimates for the retinol-binding protein, with a molecular weight (21,000) close to that for myoglobin (mol. wt 17,800). In comparison with β2--microglobulin, another low molecular weight protein (mol. wt 11,800), the elimination rate constant for myoglobin is significantly smaller and the turnover time is longer, as could be expected from the difference in molecular weight. Plasma protein binding of myoglobin could not be excluded, however.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.